Literature DB >> 4956337

Nonproteolytic, avirulent Bacillus anthracis as a live vaccine.

E S Fubra.   

Abstract

Fubra, Ernest S. (Federal Department of Veterinary Research, Vom, Nigeria). Nonproteolytic, avirulent Bacillus anthracis as a live vaccine. J. Bacteriol. 91:930-933. 1966.-A nonproteolytic mutant, derived from the Sterne strain of Bacillus anthracis by exposure to ultraviolet radiation, was used for vaccination of guinea pigs. Vaccine prepared from the parent Sterne strain was used in comparable immunization procedure. Comparison of the protection induced by the two vaccines showed that use of the nonproteolytic mutant was from 10 to 1,000 times as effective as the Sterne strain.

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4956337      PMCID： PMC315980          DOI： 10.1128/jb.91.3.930-933.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  10 in total

1.  IMMUNOLOGIC STUDIES OF ANTHRAX. III. COMPARISON OF ANTIBODY TITER AND IMMUNITY INDEX AFTER ANTHRAX IMMUNIZATION.

Authors:  F KLEIN; B W HAINES; B G MAHLANDT; R E LINCOLN
Journal:  J Immunol       Date:  1963-10       Impact factor: 5.422

2.  Immunological studies of anthrax. I. An index to determine quantitative immunization.

Authors:  I A DEARMON; F KLEIN; R E LINCOLN; B G MAHLANDT; A L FERNELIUS
Journal:  J Immunol       Date:  1961-09       Impact factor: 5.422

3.  Immunological studies of anthrox. II. Levels of immunity against Bacillus anthracis obtained with protective antigen and live vaccine.

Authors:  F KLEIN; I A DEARMON; R E LINCOLN; B G MAHLANDT; A L FERNELIUS
Journal:  J Immunol       Date:  1962-01       Impact factor: 5.422

4.  Elaboration of protective antigen of Bacillus anthracis under anaerobic conditions.

Authors:  G G WRIGHT; M PUZISS
Journal:  Nature       Date:  1957-05-04       Impact factor: 49.962

5.  Studies on a protective antigen produced in vitro from Bacillus anthracis: purification and chemistry of the antigen.

Authors:  R E STRANGE; F C BELTON
Journal:  Br J Exp Pathol       Date:  1954-04

6.  Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production.

Authors:  F C BELTON; R E STRANGE
Journal:  Br J Exp Pathol       Date:  1954-04

7.  Studies on immunity in anthrax. III. Elaboration of protective antigen in a chemically defined, non-protein medium.

Authors:  G G WRIGHT; M A HEDBERG; J B SLEIN
Journal:  J Immunol       Date:  1954-04       Impact factor: 5.422

8.  Studies on immunity in anthrax. IX. Effect of variations in cultural conditions on elaboration of protective antigen by strains of Bacillus anthracis.

Authors:  G G WRIGHT; M PUZISS; W B NEELY
Journal:  J Bacteriol       Date:  1962-03       Impact factor: 3.490

9.  Studies on immunity in anthrax. VI. Immunizing activity of protective antigen against various strains of Bacillus anthracis.

Authors:  S AUERBACH; G G WRIGHT
Journal:  J Immunol       Date:  1955-08       Impact factor: 5.422

10.  Studies on immunity in anthrax. II. In vitro elaboration of protective antigen by non-proteolytic mutants of Bacillus anthracis.

Authors:  G G WRIGHT; M A HEDBERG; R J FEINBERG
Journal:  J Exp Med       Date:  1951-06       Impact factor: 14.307
  10 in total
  1 in total

1.  Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.

Authors:  S F Little; G B Knudson
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.